AVIR

Atea Pharmaceuticals (AVIR)

About Atea Pharmaceuticals (AVIR)

Atea Pharmaceuticals, Inc. is a clinical stage company, which focuses on discovering, developing, and commercializing antiviral therapeutics. Its product pipelines include Coronaviridae, Flaviviridae, and Paramyxovirdae. The company was founded by Jean-Pierre Sommadossi and David Chu in July 2012 and is headquartered in Boston, MA.

Details

Daily high

$4.17

Daily low

$3.91

Price at open

$4.05

52 Week High

$4.34

52 Week Low

$2.46

Market cap

324.2M

Dividend yield

0.00%

Volume

323,799

Avg. volume

568,858

P/E ratio

-2.34

Atea Pharmaceuticals News